NZ599265A - A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof - Google Patents
A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereofInfo
- Publication number
- NZ599265A NZ599265A NZ599265A NZ59926510A NZ599265A NZ 599265 A NZ599265 A NZ 599265A NZ 599265 A NZ599265 A NZ 599265A NZ 59926510 A NZ59926510 A NZ 59926510A NZ 599265 A NZ599265 A NZ 599265A
- Authority
- NZ
- New Zealand
- Prior art keywords
- sugar
- salt
- skin external
- external composition
- preventing
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20090099333 | 2009-10-19 | ||
| KR1020100097774A KR101133723B1 (ko) | 2009-10-19 | 2010-10-07 | 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도 |
| PCT/KR2010/007068 WO2011049327A2 (en) | 2009-10-19 | 2010-10-15 | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ599265A true NZ599265A (en) | 2014-03-28 |
Family
ID=44048707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ599265A NZ599265A (en) | 2009-10-19 | 2010-10-15 | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20120201904A1 (enExample) |
| EP (2) | EP2490700A4 (enExample) |
| JP (2) | JP6044831B2 (enExample) |
| KR (1) | KR101133723B1 (enExample) |
| CN (1) | CN102573858B (enExample) |
| AU (1) | AU2010308741B2 (enExample) |
| BR (1) | BR112012008470A2 (enExample) |
| CA (1) | CA2778371C (enExample) |
| MX (1) | MX2012004509A (enExample) |
| MY (1) | MY182983A (enExample) |
| NZ (1) | NZ599265A (enExample) |
| PH (1) | PH12012500773A1 (enExample) |
| RU (1) | RU2536264C2 (enExample) |
| WO (1) | WO2011049327A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9433641B2 (en) * | 2009-10-19 | 2016-09-06 | Won Seog Choi | Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| JP5547123B2 (ja) * | 2011-03-30 | 2014-07-09 | 株式会社 資生堂 | 油中水型乳化化粧料 |
| KR101470282B1 (ko) * | 2013-10-01 | 2014-12-05 | 최원석 | 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도 |
| US11166968B2 (en) | 2015-09-29 | 2021-11-09 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
| KR101784847B1 (ko) * | 2016-05-10 | 2017-10-13 | 주식회사 하우동천 | 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도 |
| KR101771479B1 (ko) | 2016-12-23 | 2017-09-05 | 유한회사 아이에스티케이3 | 천연식물추출물 및 당을 유효성분으로 함유하는 질염예방 및 치료용 조성물 |
| KR102769558B1 (ko) | 2017-02-28 | 2025-02-19 | 킴벌리-클라크 월드와이드, 인크. | 미생물총의 건강한 균형을 유지하기 위한 상승적 조성물 |
| KR102091440B1 (ko) * | 2018-07-26 | 2020-03-20 | 이기용 | 질 세정제를 이용한 질 세정용 위생용품 |
| RU2726123C1 (ru) * | 2019-12-20 | 2020-07-09 | Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук | Способ лечения трихомониаза у женщин |
| KR102285430B1 (ko) | 2020-01-06 | 2021-08-04 | 주식회사 벤스랩 | 염화칼륨을 포함하는 여성세정제 조성물 |
| KR102213286B1 (ko) | 2020-07-31 | 2021-02-05 | 정소영 | 질염의 치료 및 자궁경부이형성증의 예방용 한약 조성물 |
| KR20260006643A (ko) * | 2023-06-20 | 2026-01-13 | 토요 슈가 리파이닝 컴퍼니 리미티드 | 세균의 증식 억제제, 그것을 포함하는 화장품, 의약 부외품 및 의약 조성물, 그리고 세균의 증식 억제 방법 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2823163A (en) * | 1956-10-11 | 1958-02-11 | Richard K Thoms | Antivaginitis process and cation exchange resin composition |
| IT1172185B (it) * | 1981-12-21 | 1987-06-18 | Serono Ist Farm | Composizione particolarmente per la vande vaginali |
| DE3232136A1 (de) * | 1982-08-28 | 1984-03-01 | Ruth Cegla GmbH, 7542 Schömberg | Gemisch enthaltend meersalz und/oder salinensalz |
| SE8603338D0 (sv) * | 1986-08-07 | 1986-08-07 | Bjorn Andersch | Medel for behandling av tillstand i slidan |
| US5098709A (en) * | 1987-07-21 | 1992-03-24 | Kang Kwon J | Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatment of inflammations |
| HU212426B (en) * | 1992-07-22 | 1996-06-28 | Vepex Kft | Process for producing bioactive pharmaceutical compositions |
| AU675304B2 (en) * | 1993-06-04 | 1997-01-30 | Senju Pharmaceutical Co., Ltd. | Ophthalmic topical agent |
| US5916176A (en) * | 1994-08-25 | 1999-06-29 | Caillouette; James C. | Estrogen or estradiol need determination by vaginal or urethral acidity determination |
| IL127189A0 (en) * | 1996-05-22 | 1999-09-22 | Diversified Pharmaceuticals In | Compositions methods and devices for the transdermal delivery of drugs |
| AU1223099A (en) * | 1997-11-24 | 1999-06-15 | Zhongming Zeng | Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof |
| KR20010029068A (ko) * | 1999-09-29 | 2001-04-06 | 강권중 | 죽염과 운모를 유효성분으로 함유하는 질정제 |
| RU2234325C1 (ru) * | 2003-12-10 | 2004-08-20 | ЗАО "Аэромед" | Способ лечения заболеваний влагалища и устройство для его осуществления (варианты) |
| CN100389763C (zh) * | 2004-02-10 | 2008-05-28 | 周世兰 | 改善妇女阴道酸、湿性的乳酸、甘油制剂 |
| SE528337C2 (sv) * | 2004-06-23 | 2006-10-24 | Nestor Medical Ab | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
| WO2006041423A1 (en) * | 2004-09-15 | 2006-04-20 | Wound Cure Llc | Topical wound care product containing hyssop |
| US7619008B2 (en) * | 2004-11-12 | 2009-11-17 | Kimberly-Clark Worldwide, Inc. | Xylitol for treatment of vaginal infections |
| EP1911454B1 (en) * | 2005-04-27 | 2012-01-11 | Shenzhen Phlora Biotechnology Limited | A composition and method of regulating and maintaining the vaginal bacterial flora and the normal acidity in the vagina |
| CA2640101A1 (en) * | 2006-01-24 | 2007-08-02 | Fjell & Fjord Mat As | Composition comprising sugar and salt for treating meat |
| JP5199551B2 (ja) * | 2006-07-06 | 2013-05-15 | サンスター株式会社 | カンジダ菌感染に基づく疾患の予防又は改善剤 |
| CN101530403A (zh) * | 2008-03-14 | 2009-09-16 | 郭进军 | 用于治疗或预防妇女阴道炎、宫颈糜烂的木糖醇组合物 |
| CN101797269B (zh) * | 2010-03-23 | 2012-01-04 | 杨霞 | 一种调节女性阴道微生态的生理平衡液 |
-
2010
- 2010-10-07 KR KR1020100097774A patent/KR101133723B1/ko active Active
- 2010-10-15 US US13/501,910 patent/US20120201904A1/en not_active Abandoned
- 2010-10-15 PH PH1/2012/500773A patent/PH12012500773A1/en unknown
- 2010-10-15 CN CN2010800466317A patent/CN102573858B/zh active Active
- 2010-10-15 JP JP2012534113A patent/JP6044831B2/ja active Active
- 2010-10-15 WO PCT/KR2010/007068 patent/WO2011049327A2/en not_active Ceased
- 2010-10-15 CA CA2778371A patent/CA2778371C/en active Active
- 2010-10-15 EP EP10825152.1A patent/EP2490700A4/en not_active Ceased
- 2010-10-15 NZ NZ599265A patent/NZ599265A/en unknown
- 2010-10-15 EP EP17159197.7A patent/EP3192516A1/en not_active Withdrawn
- 2010-10-15 MX MX2012004509A patent/MX2012004509A/es active IP Right Grant
- 2010-10-15 RU RU2012113101/15A patent/RU2536264C2/ru active
- 2010-10-15 MY MYPI2012001746A patent/MY182983A/en unknown
- 2010-10-15 AU AU2010308741A patent/AU2010308741B2/en active Active
- 2010-10-15 BR BR112012008470A patent/BR112012008470A2/pt not_active Application Discontinuation
-
2013
- 2013-09-12 US US14/025,698 patent/US20140037758A1/en not_active Abandoned
-
2016
- 2016-09-05 JP JP2016172680A patent/JP6429131B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017025078A (ja) | 2017-02-02 |
| AU2010308741B2 (en) | 2015-02-19 |
| JP2013508269A (ja) | 2013-03-07 |
| MY182983A (en) | 2021-02-05 |
| RU2536264C2 (ru) | 2014-12-20 |
| WO2011049327A2 (en) | 2011-04-28 |
| BR112012008470A2 (pt) | 2016-04-05 |
| JP6429131B2 (ja) | 2018-11-28 |
| CA2778371A1 (en) | 2011-04-28 |
| KR20110043448A (ko) | 2011-04-27 |
| MX2012004509A (es) | 2012-06-04 |
| CN102573858A (zh) | 2012-07-11 |
| US20140037758A1 (en) | 2014-02-06 |
| JP6044831B2 (ja) | 2016-12-14 |
| EP2490700A4 (en) | 2013-08-07 |
| EP3192516A1 (en) | 2017-07-19 |
| CA2778371C (en) | 2017-09-05 |
| RU2012113101A (ru) | 2013-11-27 |
| KR101133723B1 (ko) | 2012-04-09 |
| PH12012500773A1 (en) | 2016-10-26 |
| CN102573858B (zh) | 2013-09-18 |
| US20120201904A1 (en) | 2012-08-09 |
| WO2011049327A3 (en) | 2011-10-20 |
| AU2010308741A1 (en) | 2012-05-03 |
| HK1167348A1 (en) | 2012-11-30 |
| EP2490700A2 (en) | 2012-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12012500773A1 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| PT2210588E (pt) | Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana | |
| GB2491328A (en) | Immediate/delayed drug delivery | |
| MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| NZ602510A (en) | Treatment of lupus nephritis using laquinimod | |
| MY164730A (en) | Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
| MX338554B (es) | Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor. | |
| WO2011053792A3 (en) | Methods and compositions for sustained delivery of drugs | |
| UA95105C2 (ru) | Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения | |
| WO2011139794A3 (en) | A composition for skin sanitization and protection and method of its use | |
| MX2013013809A (es) | Dispositivos expandibles con revestimiento de una composicion de paclitaxel. | |
| MX2013002244A (es) | Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2. | |
| RU2018135973A (ru) | Фармацевтическая комбинация, содержащая метроформин и дигидрокверценин, и ее применение для лечения рака | |
| GEAP201813377A (en) | New therapeutical composition containing apomorphine as active ingredient | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| SG10201501579WA (en) | Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation | |
| BRPI0513466A (pt) | antivìrus natural e composição compreendendo o mesmo | |
| MX2012013606A (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas. | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| MX2013013808A (es) | Dispositivos expandibles con revestimiento de una composicion de rapamicina. | |
| NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
| MY163107A (en) | Pharmaceutical composition for the treatment of bladder disorders | |
| MX2008011321A (es) | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 OCT 2017 BY CALLINANS Effective date: 20140729 Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 OCT 2023 BY CALLINANS Effective date: 20140812 Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 OCT 2020 BY CALLINANS Effective date: 20140812 Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 15 OCT 2030 BY CALLINANS Effective date: 20140812 |